Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety, Tolerability, Pharmacokinetics and Pharmacodynamics”

3,573 trials

Showing 20 of 3,573 results

Early research (Phase 1)Study completedNCT01632358
What this trial is testing

Safety and Pharmacokinetis of TAP311 in Dyslipidemic Patients

Who this might be right for
Dyslipidaemia
Novartis Pharmaceuticals 279
Early research (Phase 1)Study completedNCT04056689
What this trial is testing

Study to Evaluate DNL151 in Subjects With Parkinson's Disease

Who this might be right for
Parkinson's Disease
Biogen 36
Early research (Phase 1)Study completedNCT02859701
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AK002 in Healthy Participants

Who this might be right for
Healthy
Allakos Inc. 51
Early research (Phase 1)Study completedNCT01205867
What this trial is testing

Study to Investigate the Safety and Tolerability of AZD8848 in Butyrylcholinesterase Deficient Subjects

Who this might be right for
Butyrylcholinesterase Deficiency
AstraZeneca 22
Early research (Phase 1)UnknownNCT05765006
What this trial is testing

CD19-CART(Relma-cel) for Moderate to Severe Active Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Shanghai Ming Ju Biotechnology Co., Ltd. 24
Early research (Phase 1)Study completedNCT03522506
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-925 Study in Sleep-Deprived Healthy Adults

Who this might be right for
Healthy Volunteers
Takeda 20
Early research (Phase 1)UnknownNCT05207176
What this trial is testing

Study to Evaluate the Safety and PK Properties of DWP16001 in Healthy Subjects With Various Ethnicities

Who this might be right for
Healthy
Daewoong Pharmaceutical Co. LTD. 24
Early research (Phase 1)Study completedNCT02496143
What this trial is testing

A Safety and PK Study of EC-18 in Healthy Subjects

Who this might be right for
Chemotherapy-induced Neutropenia
Enzychem Lifesciences Corporation 33
Early research (Phase 1)Study completedNCT01010425
What this trial is testing

Pharmacokinetics and Pharmacodynamics of ACP-001 (TransCon PEG hGH)

Who this might be right for
Healthy
Ascendis Pharma A/S 44
Early research (Phase 1)Study completedNCT03165240
What this trial is testing

This International Study Tests BI 690517 in Patients With Diabetic Kidney Disease. The Study Tests How 3 Different Doses of BI 690517 Are Taken up in the Body and How Well They Are Tolerated

Who this might be right for
Diabetic Nephropathies
Boehringer Ingelheim 62
Early research (Phase 1)Study completedNCT01387217
What this trial is testing

GSK2018682 FTIH in Healthy Volunteers

Who this might be right for
Multiple Sclerosis
GlaxoSmithKline 27
Early research (Phase 1)Study completedNCT04139226
What this trial is testing

Evaluate the Safety, Tolerability Pharmacokinetics, and Pharmacodynamics of a New Spray Dried Dispersion (SDD) Formulation of CC-11050 After Single Dose of CC-11050 and to Evaluate the Pharmacokinetics of CC-11050 Under Fasted and Fed Conditions and After Coadministration With Omeprazole

Who this might be right for
Healthy Volunteers
Amgen 44
Early research (Phase 1)UnknownNCT01637493
What this trial is testing

Pharmacokinetics and Pharmacodynamics Study of Pegfilgrastim in Chemotherapy Patients

Who this might be right for
Neutropenia
Hangzhou Jiuyuan Gene Engineering Co. Ltd., 24
Early research (Phase 1)Study completedNCT01809184
What this trial is testing

A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0287 in Healthy Subjects

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 84
Early research (Phase 1)Ended earlyNCT03067363
What this trial is testing

First in Human Single Ascending Dose Study of MOR107

Who this might be right for
Safety
Alan Richardson 24
Testing effectiveness (Phase 2)Study completedNCT02776033
What this trial is testing

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Repeat Doses of GSK2982772 in Subjects With Psoriasis

Who this might be right for
Psoriasis
GlaxoSmithKline 65
Testing effectiveness (Phase 2)WithdrawnNCT06147856
What this trial is testing

A Dose-finding Study to Evaluate mRNA-3210 in Participants With Phenylketonuria

Who this might be right for
Phenylketonuria
ModernaTX, Inc.
Early research (Phase 1)UnknownNCT03427853
What this trial is testing

Evaluate the Denosumab in Healthy Adults

Who this might be right for
Healthy Adults
Luye Pharma Group Ltd. 32
Early research (Phase 1)Looking for participantsNCT07167537
What this trial is testing

OL-CD19-GDT in Relapsed/ Refractory Autoimmune Diseases

Who this might be right for
Systemic Sclerosis (SSc)Primary Sjogren's Syndrome
Beijing GoBroad Hospital 44
Testing effectiveness (Phase 2)Study completedNCT05143957
What this trial is testing

Evaluate Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx) in Patients With Polycythemia Vera

Who this might be right for
Phlebotomy Dependent Polycythemia Vera
Ionis Pharmaceuticals, Inc. 50
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation